Zimmer Biomet Q2 revenue beats on technology, data growth

Zimmer Biomet Holdings

05/08/2026 11:44

Overview
U.S. medical technology firm's Q2 revenue rose 4.8%, beating analyst expectations
Adjusted EPS for Q2 was flat year-over-year and beat analyst expectations
Company raised 2026 revenue and adjusted EPS guidance, plans up to $1 bln share buyback

Outlook
Zimmer Biomet raises full-year 2026 reported revenue growth guidance to 3.9%-4.9%
Company now sees 2026 adjusted diluted EPS at $8.47-$8.59
Zimmer Biomet cites healthy markets and innovation cycle as drivers for improved outlook

Result Drivers
INNOVATION CYCLE - Co said continued momentum from its innovation cycle contributed to Q2 results, per CEO Ivan Tornos
TECHNOLOGY & DATA GROWTH - Sales in Technology & Data, Bone Cement and Surgical category grew 21.1% in Q2

Company press release: ID:nPn7YKJxDa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Beat
$2.18 bln
$2.13 bln (23 Analysts)
Q2 Adjusted EPS
Beat
$2.07
$2.009 (23 Analysts)
Q2 EPS
 
$1.03
 
Q2 Net Income
 
$198.30 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 21 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Zimmer Biomet Holdings, Inc. is $95.00, about 0.8% below its August 4 closing price of $95.81
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Reuters Recommended Reads
Aug 4 - UK's Smith+Nephew cuts 2026 revenue view on weak US knee implant demand
Aug 4 - OrthoPediatrics Q2 revenue rises 15%, beats estimates
Aug 4 - Alphatec Q2 revenue beats estimates on strong surgical case volume

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)